A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT02068352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the effectiveness and safety of 2 concentrations of OPA-15406 compared to vehicle in participants with atopic dermatitis (AD).
Study identification
- NCT ID
- NCT02068352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2014 (Actual)
- Primary completion
- Jan 28, 2015 (Actual)
- Completion
- Feb 3, 2015 (Actual)
- Last update posted
- Nov 23, 2021
2014 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90045 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | Orange Park | Florida | 32065 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Arlington Heights | Illinois | 60005 | — |
| Not listed | Carmel | Indiana | 46032 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Verona | New Jersey | 07044 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Stony Brook | New York | 11790 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Portland | Oregon | 97239-4501 | — |
| Not listed | Austin | Texas | 78759 | — |
| Not listed | College Station | Texas | 77845 | — |
| Not listed | Houston | Texas | 77065 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02068352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02068352 live on ClinicalTrials.gov.